NEW YORK (GenomeWeb News) – Invitrogen said after the close of the market on Tuesday that it has received US Food and Drug Administration clearance to sell its new transplant diagnostics system.
The Carlsbad, Calif.-based firm received 510(k) clearance for its DynaChip Antibody Analysis System, an automated chip-based system for human leukocyte antibody detection and identification. The tests are run on protein arrays developed by the company.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.